Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?
![Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/42e5e18ddb21d203ac8e661da38f5929.jpg)
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially...
show moreInformation
Author | cancerGRACE |
Organization | cancerGRACE |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company